NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database
In Brief: ACCC Honors Henry Lynch; Gunderson Names Chair, Mayo Oncology Department
PDQ Needs Change, Advocates Say, NBCC to Build Its Own Trials Registry
Richard Bloch’s Dream Of Empowering Patients Had Rough Beginning
Professional Societies: Three Groups To File brief In Fisher’s Appeal
NCI News: Communications Office Seeks Partners for Education Programs
Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









